Use of cabergoline for the ovarian hyperstimulation syndrome prevention

被引：0
|
作者：
Merino, V. Verdu [1 ]
Gonzalez-Villafanez, V. [1 ]
Alarcon, M. [1 ]
Lopez, L. [1 ]
Lopez-Yanez, L. [1 ]
de Segura, R. Gomez [1 ]
Arenas, J. M. Bajo [1 ]
机构：
[1] Ginefiv, Madrid, Spain
来源：
HUMAN REPRODUCTION | 2007年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P373
引用
收藏
页码：I146 / I147
页数：3
相关论文
共 50 条
  • [1] The Effectiveness of Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome
    Hosseini, Marzieh Agha
    Aleyasin, Ashraf
    Mahdavi, Atossa
    Nezami, Romina
    Safdarian, Leila
    Fallahi, Parvin
    [J]. IRANIAN JOURNAL OF MEDICAL SCIENCES, 2011, 36 (03) : 207 - 212
  • [2] CABERGOLINE IN PREVENTION AND TREATMENT OF OVARIAN HYPERSTIMULATION SYNDROME
    Dosedla, Erik
    Gasparova, Petra
    Ballova, Zuzana
    Sitas, Martina
    Turcsanyiova, Zuzana
    Calda, Pavel
    [J]. AKTUALNI GYNEKOLOGIE A PORODNICTVI, 2023, 15 : 49 - 54
  • [3] Cabergoline for preventing ovarian hyperstimulation syndrome
    Tang, Huilin
    Hunter, Tamara
    Hu, Yongfang
    Zhai, Suo-Di
    Sheng, Xiaoyan
    Hart, Roger J
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (02):
  • [4] Use of cabergoline and post-collection GnRH antagonist administration for prevention of ovarian hyperstimulation syndrome
    Shrem, Guy
    Steiner, Naama
    Balayla, Jacques
    Volodarsky-Perel, Alexander
    Tannus, Samer
    Son, Weon-Young
    Dahan, Michael H.
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2019, 39 (03) : 433 - 438
  • [5] Cabergoline as treatment of ovarian hyperstimulation syndrome: a review
    Kalampokas, Theodoros
    Creatsas, George
    Kalampokas, Emmanouil
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2013, 29 (02) : 98 - 100
  • [6] CLINICAL UTILITY OF CABERGOLINE IN OVARIAN HYPERSTIMULATION SYNDROME
    Nagore Setien, D.
    Monedero, P.
    Alcazar, J. L.
    [J]. REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION, 2011, 58 (02): : 132 - 133
  • [7] CABERGOLINE USE IN PATIENTS WITH OVARIAN HYPERSTIMULATION SYNDROME INFLUENCES THE RATE OF PREGNANCY?
    Macedo, J. F.
    Gomes, L. M. O.
    Melo, K. R. B.
    [J]. FERTILITY AND STERILITY, 2013, 100 (03) : S342 - S342
  • [8] Comparison of albumin and cabergoline in the prevention of ovarian hyperstimulation syndrome: A clinical trial study
    Torabizadeh, Aalie
    Vahidroodsari, Fatemeh
    Ghorbanpour, Zakieh
    [J]. IRANIAN JOURNAL OF REPRODUCTIVE MEDICINE, 2013, 11 (10) : 837 - 842
  • [9] Comparison of montelukast and cabergoline for prevention of ovarian hyperstimulation syndrome: in an experimental rat model
    Akman, Levent
    Sahin, Gulnaz
    Erbas, Oytun
    Aktug, Huseyin
    Akdogan, Aysin
    Goker, Ege Nazan Tavmergen
    Taskiran, Dilek
    Tavmergen, Erol
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2015, 31 (05) : 369 - 373
  • [10] Prevention of ovarian hyperstimulation syndrome in a rat model: efficacy comparison between cabergoline and meloxicam
    Saylan, Arif
    Arioz, Dagistan Tolga
    Koken, Tulay
    Dilek, Husniye
    Saylan, Filiz
    Yilmazer, Mehmet
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2010, 89 (05) : 692 - 699
12345